Key result
ECT linked to 14-day delirium in a male with substance misuse and ischemic brain changes.
Why the study?
Prolonged post-ECT delirium is a rare but serious adverse effect with unclear contributing factors including brain pathologies and substance misuse.
Case Report (n=1)
Highlights the importance of screening for risk factors like substance misuse and ischemic brain changes before ECT to prevent prolonged delirium.
May indicate risk of prolonged post-ECT delirium with substance misuse and ischemic changes; leaves open need for prospective risk studies.
Electroconvulsive therapy (ECT) is an effective treatment for various psychiatric conditions. Although rare, prolonged post-ECT delirium is a serious adverse effect of ECT. Various factors, such as underlying brain pathologies, medications, seizure duration, and type of electrode placements play a role in the development of post-ECT delirium. We report a 56-year-old male suffering from 14-day-long post-ECT delirium associated with substance misuse, pesticide exposure, as well as ischemic brain changes. On the basis of the insights from this case, it may be suggested that all patients should be screened for risk factors associated with ECT-related delirium before ECT and that various parameters, such as electrode placement and medications, should be adjusted accordingly.
No takes yet. Share an insight, caveat, or question.
Köroğlu et al. (2021) conducted a case report in Prolonged post-ECT delirium (n=1). Electroconvulsive therapy (ECT) was evaluated on Prolonged post-ECT delirium. Electroconvulsive therapy (ECT) was associated with a 14-day-long post-ECT delirium in a 56-year-old male with substance misuse, pesticide exposure, and ischemic brain changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: